Point72 Asset Management’s Clovis Oncology, Inc. CLVS Stock Holding History

Point72 Asset Management’s Portfolio CLVS Stock Details CLVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-1,802,756	Closed	-$8.65M	–	1257
2020 Q4	$8.65M	Buy	+1,802,756	New	+$9.12M	0.04%	472
2020 Q2	–	Sell	-46,800	Closed	-$298K	–	1084
2020 Q1	$298K	Buy	+46,800	New	+$375K	﹤0.01%	695
2019 Q2	–	Sell	-587,318	Closed	-$14.6M	–	1611
2019 Q1	$14.6M	Buy	587,318 +460,518	+363%	+$11.5M	0.07%	320
2018 Q4	$2.28M	Sell	126,800 -2,200	-2%	-$45K	0.01%	697
2018 Q3	$3.79M	Sell	129,000 -36,000	-22%	-$1.39M	0.02%	658
2018 Q2	$7.5M	Sell	165,000 -990,937	-86%	-$48.2M	0.03%	507
2018 Q1	$61M	Buy	1,155,937 +279,937	+32%	+$16.3M	0.26%	105
2017 Q4	$59.6M	Buy	+876,000	New	+$61.2M	0.26%	105
2017 Q3	–	Sell	-30,000	Closed	-$2.81M	–	1109
2017 Q2	$2.81M	Buy	+30,000	New	+$1.84M	0.02%	598

Other funds holding CLVS

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Point72 Asset Management's CLVS Position: Q1 2021 in Review

Point72 Asset Management sold out of Clovis Oncology, Inc. (CLVS) in Q1 2021, closing a stake of 1,802,756 shares — an estimated $8.65M sold.

Point72 Asset Management first reported a position in CLVS in Q2 2017 and held it in 9 quarters. The position peaked at $61M in Q1 2018. 165 funds tracked by Wall St. Rank hold CLVS as of Q1 2021.

Point72 Asset Management reported no remaining Clovis Oncology, Inc. position as of Q1 2021 after selling out during the quarter.
Point72 Asset Management sold 1,802,756 Clovis Oncology, Inc. shares in Q1 2021, an estimated $8.65M.
Point72 Asset Management first reported a position in Clovis Oncology, Inc. in Q2 2017 and held it in 9 quarters.
Point72 Asset Management's Clovis Oncology, Inc. position peaked at $61M in Q1 2018.
165 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q1 2021.

Based on Point72 Asset Management's 13F filing for Q1 2021, filed 17 May 2021.